Ensign Peak Advisors Inc Sells 3,445 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Ensign Peak Advisors Inc lessened its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,409 shares of the company’s stock after selling 3,445 shares during the period. Ensign Peak Advisors Inc’s holdings in Acadia Healthcare were worth $2,121,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. New York State Teachers Retirement System boosted its holdings in shares of Acadia Healthcare by 0.3% in the 1st quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock valued at $6,025,000 after purchasing an additional 200 shares in the last quarter. Blue Trust Inc. boosted its stake in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after buying an additional 248 shares in the last quarter. Commonwealth Equity Services LLC grew its position in Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after acquiring an additional 257 shares during the last quarter. Quent Capital LLC raised its stake in Acadia Healthcare by 8.1% during the first quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after acquiring an additional 284 shares in the last quarter. Finally, Retirement Systems of Alabama boosted its stake in shares of Acadia Healthcare by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock valued at $9,174,000 after purchasing an additional 303 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC opened at $63.28 on Friday. The business has a 50-day moving average of $74.23 and a 200-day moving average of $71.72. Acadia Healthcare Company, Inc. has a 1 year low of $53.22 and a 1 year high of $87.77. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of -452.00, a price-to-earnings-growth ratio of 2.19 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm had revenue of $796.00 million for the quarter, compared to the consensus estimate of $784.38 million. During the same quarter in the previous year, the company earned $0.92 EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. As a group, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research report on Monday, August 19th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Finally, Barclays dropped their target price on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $87.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.